Dr. Pamela Lyn Kunz, MD is a Hematology / Oncology Specialist - Hematologist (Blood) practicing in Palo Alto, CA
She has not yet shared a personalized biography with Doctor.com.
| Institution | Focus | Year |
|---|---|---|
| Internship - Stanford University School of Medicine,Stanford, Ca, United States | 2002 | |
| Residency - Stanford University School of Medicine | 2005 | |
| Fellowship - Stanford University School of Medicine,Stanford, Ca, United States | 2007 |
| Certification | Cert. Body | Year |
|---|---|---|
| Radiation Oncology | Radiology | 2010 |
Sub-Specialty: Medical Oncology | Internal Medicine | 2010 |
| Position | Organization | Time |
|---|---|---|
| Assistant Professor of Medicine (Oncology) | the Stanford University Medical Center | Present |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | HPB | Pancreatic neuroendocrine tumours | 2014 |
| Other Publication | JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | Reassessment of the Current American Joint Committee on Cancer Staging System | 2014 |
| Other Publication | ANNALS OF SURGICAL ONCOLOGY | Seventh Edition (2010) of the AJCC | 2013 |
| Other Publication | PANCREAS | Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors | 2013 |
| Other Publication | PLOS ONE | Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET | 2013 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Everolimus Causing Severe Hypertriglyceridemia and Acute Pancreatitis | 2013 |
| Other Publication | INVESTIGATIONAL NEW DRUGS | Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 | 2012 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Neoadjuvant Imatinib for Borderline Resectable GIST | 2012 |
| Other Publication | AMERICAN JOURNAL OF CARDIOLOGY | Capecitabine-Induced Chest Pain Relieved by Diltiazem | 2012 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Long-Term Survivors of Gastric Cancer: A California Population-Based Study | 2012 |
| Other Publication | MODERN PATHOLOGY | Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma | 2012 |
| Other Publication | ANNALS OF SURGICAL ONCOLOGY | Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis | 2012 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Neuroendocrine Tumors Clinical Practice Guidelines in Oncology | 2012 |
| Other Publication | Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., | Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma | 2012 |
| Other Publication | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population | 2012 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF | 2011 |
| Other Publication | CANCER | Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell | 2011 |
| Other Publication | ARCHIVES OF SURGERY | Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement | 2011 |
| Other Publication | NUCLEAR MEDICINE COMMUNICATIONS | F-18-5-fluorouracil dynamic positron emission tomography | 2011 |
| Other Publication | Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A. | Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate | 2010 |
| Other Publication | Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., No | Comparison of Intensity-Modulated Radiotherapy | 2010 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | (18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION | 2010 |
| Other Publication | COLORECTAL DISEASE | Pathological response after chemoradiation for T3 rectal cancer | 2010 |
| Other Publication | Colorectal disease | Pathological response after chemoradiation for T3 rectal cancer. | 2010 |
| Other Publication | Clinical and experimental gastroenterology | Advances in the treatment of gastroenteropancreatic neuroendocrine tumors. | 2010 |
| Other Publication | DISEASES OF THE ESOPHAGUS | Multimodality treatment with intensity modulated radiation therapy for esophageal cancer | 2010 |
| Other Publication | JOURNAL OF TRANSLATIONAL MEDICINE | Identification of a biomarker panel using a multiplex proximity ligation | 2009 |
| Other Publication | JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | Escherichia coli O157 : H7 infection in nursing homes | 2006 |
| Other Publication | GASTROINTESTINAL ENDOSCOPY | Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus | 2004 |
| Other Publication | PEDIATRIC NEUROLOGY | Tandem mass spectrometry and newborn screening: Pilot data and review | 2002 |
| Other Publication | MOLECULAR GENETICS AND METABOLISM | Molecular analysis and prenatal diagnosis of human fumarase deficiency | 1998 |
| Other Publication | JOURL OF THE AMERICAN COLLEGE OF SURGEONS | Reassessment of the Current American Joint Committee on Cancer Staging System | 2014 |
| Other Publication | ANLS OF SURGICAL ONCOLOGY | Seventh Edition (2010) of the AJCC | 2013 |
| Other Publication | PANCREAS | Consensus Guidelines for the Magement and Treatment of Neuroendocrine Tumors | 2013 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Everolimus Causing Severe Hypertriglyceridemia and Acute Pancreatitis | 2013 |
| Other Publication | INVESTIGATIOL NEW DRUGS | Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 | 2012 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Neoadjuvant Imatinib for Borderline Resectable GIST | 2012 |
| Other Publication | AMERICAN JOURL OF CARDIOLOGY | Capecitabine-Induced Chest Pain Relieved by Diltiazem | 2012 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Long-Term Survivors of Gastric Cancer: A California Population-Based Study | 2012 |
| Other Publication | ANLS OF SURGICAL ONCOLOGY | Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis | 2012 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Neuroendocrine Tumors Clinical Practice Guidelines in Oncology | 2012 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF | 2011 |
| Other Publication | CANCER | Intensity-Modulated Radiation Therapy Versus Conventiol Radiation Therapy for Squamous Cell | 2011 |
| Other Publication | NUCLEAR MEDICINE COMMUNICATIONS | F-18-5-fluorouracil dymic positron emission tomography | 2011 |
| Other Publication | Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., No | Comparison of Intensity-Modulated Radiotherapy | 2010 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | (18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION | 2010 |
| Other Publication | JOURL OF TRANSLATIOL MEDICINE | Identification of a biomarker panel using a multiplex proximity ligation | 2009 |
| Other Publication | JOURL OF THE AMERICAN GERIATRICS SOCIETY | Escherichia coli O157 : H7 infection in nursing homes | 2006 |
| Other Publication | GASTROINTESTIL ENDOSCOPY | Cost-effectiveness of photodymic therapy for high-grade dysplasia in Barrett's esophagus | 2004 |
| Other Publication | MOLECULAR GENETICS AND METABOLISM | Molecular alysis and pretal diagnosis of human fumarase deficiency | 1998 |
Dr. Pamela Lyn Kunz, MD has not yet indicated the hospitals that she is affiliated with.
Years In Practice: 16 (started in 2008)
Accepts New Patients: Yes
Dr. Pamela Lyn Kunz, MD has not yet listed the medications that she commonly prescribes.
Dr. Pamela Lyn Kunz, MD has not yet added any information about her practice's billing policies and payment options.
